How to Hire a Managing Director: A Complete Guide for UK Companies

The Managing Director is one of the most consequential and most variable senior appointments a UK business makes. The title covers leaders running standalone businesses, divisional heads within larger groups, country managing directors of international firms, operational leaders of professional services partnerships, and the senior executive of a subsidiary inside a private equity-backed structure. The substance of the job differs in each setting. What stays constant is that the MD is usually the person most directly accountable for the commercial and operational performance of the business or business unit they run — and the appointment shapes that performance for several years. Get it right and the executive team, the customer base and the relationship with shareholders or the parent company all strengthen. Get it wrong and the cost is measured in lost momentum, a disrupted senior team and a second search eighteen months later.

This guide is written for chairs, CEOs, group executives, founders and shareholders working through Managing Director succession at UK firms. It sets out what an MD appointment actually involves: when the business needs an MD rather than a CEO or a senior functional director, what the role covers across different structures, what the candidate pool looks like, how to write the brief, how the search should run, how to assess and reward candidates, the legal and governance points to settle before day one, and what the first hundred days should look like. For our search service across permanent, interim and fractional engagements, see Managing Director recruitment.

The Managing Director role and how it differs from CEO

The MD and CEO titles overlap substantially in UK business, and the boundary depends on the structure of the firm rather than on any fixed definition. Neither title is a statutory office. Under company law a person is either a director of the company or not, and every director carries the same general duties; “Managing Director” describes an executive role the board has delegated, not a separate legal category. That matters later, when you decide whether your new MD will also be appointed to the board.

• In standalone businesses, the senior leader is a CEO or an MD depending on the firm’s preference, with essentially the same accountability: strategic direction, commercial performance, executive team leadership and board engagement. The MD title is more common in established UK businesses, professional services, manufacturing and services firms; the CEO title is more common in technology firms, scale-ups and businesses with a US-influenced culture.
• In group structures, the MD typically leads a subsidiary, division or business unit, reporting to a group CEO, a parent-company executive or a private equity sponsor. The role carries operational and commercial accountability for the unit but works within a parent framework that sets strategy, capital allocation, governance and group-level decisions. This is the most common pattern for MD appointments in the UK mid-market and in PE-backed businesses.
• In international structures, the Country MD or Regional MD leads the UK or regional operations of a global group, usually reporting to a regional or global executive who retains strategic authority. The role is heavily operational and commercial, with strategic latitude varying by group.
• In professional services partnerships, the MD title sometimes covers the senior partner running the firm operationally, while the equity partnership sets strategic direction collectively.

For boards approaching succession, the cleanest first decision is whether the business needs a CEO with full strategic authority or an MD with operational and commercial authority inside a defined framework. The candidate pools, the pay envelopes and the search dynamics all differ. Our comparison of Managing Director and CEO responsibilities sets out the distinction in more detail.

When does a firm need an MD?

Five situations typically warrant a Managing Director appointment.

The firm is a standalone business of meaningful scale. Independent SMEs, mid-market private businesses and family-controlled companies typically appoint an MD as the senior operating leader, with the chair — often the founder or majority shareholder — retaining strategic and governance authority above the MD.

The firm is a subsidiary or division within a group. Group structures usually appoint an MD for each operating business, providing local commercial leadership while strategic direction sits with the group executive. PE-backed portfolio companies, divisions within larger corporates and international subsidiaries all follow this pattern.

Founder transition. Founder-led businesses often appoint an MD as the founder steps back from day-to-day operational leadership while staying on as chair or executive chair. The MD takes operational accountability; the founder keeps the strategic and shareholder relationships. Handled badly, this is where MD appointments most often fail, because the boundary between the two roles is never written down. Our founder-to-CEO transition guide covers the same dynamics for the first non-founder chief executive.

Business model change. Firms moving from founder-led to professionally managed structures, scale-ups reaching the point where executive specialisation becomes necessary, and businesses working through a post-acquisition integration all typically need an MD with the operating discipline to carry the change.

Regulated business contexts. Firms operating under specific regulatory frameworks — financial services, healthcare, energy — often appoint an MD as the operating leader holding regulatory accountability for the business unit. In financial services this can bring the role within the regulator’s approval regime, which adds time and preparation to the search.

What an MD actually does

The substantive work of the role splits into four areas, with the balance varying by structure.

Commercial leadership. Whether the business delivers commercial results — revenue, margin, customer outcomes, market position. The MD is usually the senior leader most directly accountable for whether the business hits its numbers, and the role is judged on this before anything else.

Operational leadership. Whether the business actually works — delivery, customer service, supply chain reliability, process efficiency. In smaller businesses without a separate COO, the operational dimension sits squarely with the MD.

Executive team leadership. Building and leading the senior team — recruiting, developing and, where necessary, replacing the leaders below the MD. Strong MDs build teams that outlast their own tenure; weaker MDs leave teams that struggle without them.

Stakeholder management. Managing the relationships above the MD — chair, board, shareholders, parent company, PE sponsor — and outside the business with major customers, partners, lenders and, where relevant, regulators. In group structures the MD’s effectiveness depends heavily on how well the parent–subsidiary relationship is run. A written Managing Director job description that sets out these four areas, and the decisions reserved to the board or parent, is the foundation of a good brief.

The MD candidate pool

The UK MD candidate pool is reasonably deep but varies considerably by structure and sector. Five pools recur across the searches we run.

• Sitting MDs at peer firms. The most common pool — candidates currently holding the MD role at another business of similar size, sector and structure. They have shown they can do the job and bring direct sector experience, but they are also the hardest to move and the most expensive.
• Senior functional directors stepping up. Typically a commercial director, COO or CFO at a larger business who is ready for the MD seat at a smaller firm or business unit. The key question is whether their experience extends beyond their own function.
• Group executives moving into operating roles. Senior executives from larger groups who want direct commercial accountability for a business — a common route into PE-backed portfolio company MD roles.
• Advisory and consulting transitions. Partners and directors moving from advisory work into operating roles. They bring strong commercial and analytical depth; the test is whether they have already made the move from advising to owning outcomes.
• Industry-specialist MDs. Where the business operates in a sector with specific dynamics — regulated industries, niche manufacturing, professional services — candidates with long sector experience bring credentials a generalist cannot.

Most strong MD shortlists combine two or three of these pools. Restricting the search to sitting MDs in the same sector narrows the field and often filters out the candidate who would have been the best fit.

Engagement models

We place MDs across all three engagement models. Permanent appointments are the most common and the natural fit for a role whose value depends on continuity. An interim Managing Director is common during transitions — bridging the gap between MDs, leading a turnaround or transformation period, or covering extended absence. Interim MDs are usually available far faster than permanent candidates, who typically have long notice periods to serve.

A fractional Managing Director suits smaller businesses where the scale does not yet justify a full-time appointment but where senior commercial leadership is needed, often for two or three days a week. Fractional arrangements also work as a bridge: a founder-led business can test the shape of the MD role before committing to a permanent hire. The right model depends on the problem the business is solving, how long it will take to solve, and whether the role needs to be there in three years’ time.

Writing the MD brief

Most MD searches that drift do so because the brief was never settled. Strong candidates read a brief carefully, and an unclear one tells them the board has not decided what it wants. Before the search starts, the brief should answer six questions:

• Which structure is this? Standalone, subsidiary, international or partnership — and therefore how much strategic authority the MD actually has.
• Who does the MD report to, and which decisions are reserved to the board, the parent or the shareholders?
• What does success look like at the end of year one and year three, in commercial and operational terms?
• What team will the MD inherit, and do they have the authority to change it?
• Will the MD sit on the board as a statutory director?
• What is the realistic package, including any equity, and has it been tested against the market rather than internal precedent?

Where a founder or chair is staying involved, the brief should also record how the two roles divide. Candidates will ask, and a clear answer is one of the strongest signals a business can give that the MD will be allowed to do the job.

The search process and timeline

A well-run MD search has six phases: brief, market mapping, shortlist, interviews, selection and onboarding. The structure mirrors other C-suite searches, with MD-specific considerations at each stage.

• Brief. More upfront work than most searches, because the structure and authority questions above have to be answered first.
• Market mapping. Identifying candidates across the pools that fit the brief, including people who are not actively looking.
• Shortlist. A small number of assessed, interested candidates, each with a clear note on why they fit and where the risks lie.
• Interviews. Focused more on commercial track record and operational depth than on strategic vision, which is more central to CEO assessment.
• Selection. References, offer and negotiation, including equity terms where they apply.
• Onboarding. Support through notice and into the first months in role.

Timelines depend on the seniority of the role, the depth of the pool and how quickly the board makes decisions. A permanent MD search usually runs for several months from brief to accepted offer, and the notice period of a sitting MD can then add a further three to six months before they start. Building that into the plan — and deciding early whether interim cover is needed — avoids a leadership gap. In PE-backed businesses, the sponsor’s own timetable often drives the pace; our private equity executive search work is built around that.

Assessment: how to evaluate MD candidates

MD assessment combines commercial track record with operational depth and the ability to manage stakeholders.

Commercial track record. Strong MD candidates can explain their commercial contribution in numbers they can defend — revenue and margin improvement, market share, key customer outcomes, a profitability turnaround. A case-style discussion of the specific commercial challenges your business faces — pricing, channel mix, customer concentration, geographic expansion — surfaces this far better than generic competency interviews.

Operational depth. This is what separates strong MDs from senior commercial executives promoted too early. Strong MDs can engage properly with operational performance, supply chain, customer service and the mechanics of the business — not at technical-specialist level, but deeply enough to lead operational decisions credibly.

Stakeholder management. Particularly relevant in group structures. References from previous chairs, group executives or PE sponsors the candidate has worked with provide the most reliable evidence. Ask specifically how the candidate handled a disagreement with the board or parent.

The area that most rewards structured behavioural assessment is whether the candidate can run the business through the difficult moments that recur in every MD’s tenure: losing a major customer, an operational failure, a board disagreement, pressure from the parent company. Our guide to behavioural interview questions for Managing Directors sets out what to ask and what good answers sound like.

Compensation

UK MD packages are built from the usual four components — base salary, annual bonus, long-term incentives and benefits — and typically sit a tier below CEO pay at a business of equivalent size. The levels vary widely with size, sector, structure and location, so the package should be set against current market evidence for the specific role rather than a general benchmark.

• SME and standalone mid-market MDs usually combine a base salary with a meaningful annual bonus tied to profit, with equity participation depending on the ownership structure.
• PE-backed MDs typically carry a larger variable element, with long-term reward coming through a management incentive plan or sweet equity that pays out on exit.
• Group subsidiary and divisional MDs usually follow the parent’s senior management pay framework, with any equity through parent-company share plans.

The most common mistake is anchoring the package on what the previous MD was paid. If the business has grown, or the role has changed, that number is no longer the right reference point, and the strongest candidates will simply not engage.

Legal and governance points to settle before appointment

If the MD is to be appointed to the board, they take on the general duties of a director set out in sections 171 to 177 of the Companies Act 2006: acting within the company’s powers, promoting the success of the company, exercising independent judgement, exercising reasonable care, skill and diligence, avoiding conflicts of interest, not accepting benefits from third parties, and declaring interests in proposed transactions. Candidates moving from functional roles who have not sat on a board before should understand what that means in practice, and the board should be clear that a title alone does not create those duties — appointment as a director does.

Identity verification is now part of every director appointment. Companies House confirmed that from 18 November 2025 new directors must verify their identity before they can be appointed, with existing directors confirming verification at their next confirmation statement during a twelve-month transition. Acting as a director without being verified is an offence, so build verification into the offer and onboarding timetable rather than leaving it to the week the MD starts.

For listed groups and businesses that follow it voluntarily, the FRC’s UK Corporate Governance Code 2024 sets expectations on board composition, succession planning and the division of responsibilities between the chair and the executive. Private businesses do not have to apply it, but its principles on succession and clear lines of authority are a useful test for any MD appointment. Directors new to the board may also benefit from formal training such as the Institute of Directors’ Certificate in Company Direction.

In FCA-regulated firms, an MD role may also need regulatory approval as a senior manager function, which has to be planned into the search timetable. Check the position against the firm’s current regulatory framework before the role is advertised.

Common search pitfalls

Five patterns recur in MD searches that run into trouble.

• Confusing CEO and MD scope. Specifications that never say whether the role carries strategic authority or operates within a parent framework.
• Under-specifying the parent or shareholder relationship. Strong candidates probe this carefully, and vague answers lose them.
• Hiring a copy of the previous MD when the business’s situation has moved on.
• A package anchored on internal precedent rather than the current market.
• Underestimating the operational depth required, particularly for candidates stepping up from senior commercial roles.

The first hundred days

The search does not end at the signed offer. The first hundred days decide whether the appointment settles or starts to wobble. A good plan covers three things. First, listening: time with the senior team, key customers, suppliers and front-line staff before major decisions are made. Second, an agreed early view of the business — what is working, what is not and where the MD intends to focus — shared with the chair or parent so expectations are aligned. Third, an early decision on the senior team: who stays, who needs support and where gaps exist.

The board’s job in this period is to give the new MD access and cover, and to resist second-guessing decisions in the first few weeks. Where a founder or former MD remains in the business, a clear handover and a visible step back matter more than anything else. Our executive onboarding guide covers the first ninety days in more detail.

How Exec Capital approaches MD mandates

Exec Capital runs MD searches as commercial and operational leadership appointments. The track record, operational depth, team-building and stakeholder dimensions all receive the same rigour we bring to any senior search, and the structure and reporting-line questions are settled in the brief before we approach the market. We work on a retained basis, with our involvement continuing through to the candidate’s first day in role and beyond.

Our practice covers UK SME, mid-market, PE-backed, scale-up and corporate businesses across most sectors, with permanent, interim and fractional MD appointments depending on what the business needs. Every search is run by our specialist team, with Adrian Lawrence FCA overseeing each mandate. If you are starting MD succession, weighing whether an existing leader should step up, or deciding between an MD and a CEO, our MD search team can talk it through with you.

Frequently asked questions

Is a Managing Director the same as a CEO?

In a standalone business the roles are often the same in substance and the title is a matter of preference. In a group, the MD usually runs a subsidiary or division within a framework set by a group CEO or parent, so the strategic authority is narrower.

Does a Managing Director have to be a company director?

No. Managing Director is an executive title, not a statutory office. Many MDs are appointed to the board, in which case they take on the full general duties of a director and must verify their identity with Companies House; some divisional MDs are not.

How long does it take to hire a Managing Director?

A permanent search usually takes several months from brief to accepted offer, followed by the candidate’s notice period. Interim and fractional MDs can usually start much sooner, which is why they are often used to cover the gap.

Should we promote internally or search externally?

Assess internal candidates against the same brief as external ones. A benchmarked search gives the board confidence either way: if the internal candidate is the strongest, they start with a clear mandate.

When does a fractional MD make sense?

When the business needs senior commercial and operational leadership but is not yet large enough to justify a full-time MD, or when a founder wants to test the role before committing to a permanent hire.